Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

Bronte, Vincenzo, Brandau, Sven, Chen, Shu-Hsia, Colombo, Mario P., Frey, Alan B., Greten, Tim F., Mandruzzato, Susanna, Murray, Peter J. +7 more·2016·Nature Communications

Cited by (1,003)

Items 801–900 of 1,003

  1. Neutrophil biology in injuries and diseases of the central and peripheral nervous systems
    Brian M. Balog, Anisha Sonti, Richard E. Zigmond · 2023 · Progress in Neurobiology
  2. Revisiting of TAMs in tumor immune microenvironment: Insight from NF-κB signaling pathway
    Rui He, Yan He, Ran Du, Chenxin Liu, Zeran Chen, Anqi Zeng, Linjiang Song · 2023 · Biomedicine & Pharmacotherapy
  3. Surface CD52, CD84, and PTGER2 mark mature PMN-MDSCs from cancer patients and G-CSF-treated donors
    Francesca Pettinella, Barbara Mariotti, Chiara Lattanzi, Kirsten Bruderek, Marta Donini, Sara Eleotério Costa, Olivia Marini, Giulia Iannoto, Sara Gasperini, Elena Caveggion et al. · 2024 · Cell Reports Medicine
  4. THBS1+ myeloid cells expand in SLD hepatocellular carcinoma and contribute to immunosuppression and unfavorable prognosis through TREM1
    Julie Giraud, Domitille Chalopin, Eloïse Ramel, Thomas Boyer, Atika Zouine, Marie‐Alix Derieppe, Nicolas Larmonier, Olivier Adotévi, Brigitte Le Bail, Jean‐Frédéric Blanc et al. · 2024 · Cell Reports
  5. Biochemistry, pharmacology, and in vivo function of arginases
    Sophia K. Heuser, Junjie Li, Silke Pudewell, Anthea LoBue, Zhixin Li, Miriam Margherita Cortese-Krott · 2024 · Pharmacological Reviews
  6. Immunosuppressive activity of tumor-infiltrating myeloid cells in patients with meningioma
    Laura Pinton, Samantha Solito, Elena Masetto, Marina Vettore, Stefania Canè, Alessandro Della Puppa, Susanna Mandruzzato · 2018 · OncoImmunology
  7. The blood mMDSC to DC ratio is a sensitive and easy to assess independent predictive factor for epithelial ovarian cancer survival
    Saskia J A M Santegoets, Anne F. de Groot, Eveline M. Dijkgraaf, A. M. Carnaz Simões, Vera E. van der Noord, J. J. van Ham, Marij J.P. Welters, Judith R. Kroep, Sjoerd H. van der Burg · 2018 · OncoImmunology
  8. Circulating and tumor‑infiltrating myeloid‑derived suppressor cells in cervical carcinoma patients
    Liangliang Wu, Hongyu Liu, Hongchuan Guo, Qiong Wu, Songyan Yu, Yuanyuan Qin, Gang Wang, Qiyan Wu, Rong Zhang, Lingxiong Wang et al. · 2018 · Oncology Letters
  9. Valproic acid attenuates immunosuppressive function of myeloid-derived suppressor cells
    Zhiqi Xie, Yukio Ago, Naoki Okada, Masashi Tachibana · 2018 · Journal of Pharmacological Sciences
  10. SIRPα/CD47 axis controls the maintenance of transplant tolerance sustained by myeloid-derived suppressor cells
    Sabrina Pengam, Justine Durand, Claire Usal, Vanessa Gauttier, Nahzli Dilek, Bernard Martinet, Véronique Daguin, Caroline Mary, Virginie Thépenier, Géraldine Teppaz et al. · 2019 · American Journal of Transplantation
  11. Modulation of the functions of myeloid‐derived suppressor cells : a new strategy of hydrogen sulfide anti‐cancer effects
    Paola De Cicco, Giuseppe Ercolano, Valentina Rubino, Giuseppe Terrazzano, Giuseppina Ruggiero, Giuseppe Cirino, Angela Ianaro · 2019 · British Journal of Pharmacology
  12. Quantification of Early-Stage Myeloid-Derived Suppressor Cells in Cancer Requires Excluding Basophils
    Anm Nazmul H. Khan, Tiffany Rose Emmons, Jerry Thwin Wong, Emad Alqassim, Kelly L. Singel, Jaron Mark, Brandon E. Smith, Joseph Dennis Tario, Kevin Hasegawa Eng, Kirsten B. Moysich et al. · 2020 · Cancer Immunology Research
  13. Efficiently restoring the tumoricidal immunity against resistant malignancies via an immune nanomodulator
    Chen Chen, Aning Li, Peng Sun, Jiawen Xu, Wei Du, Jing Zhang, Ying Liu, Rui Zhang, Shengchang Zhang, Zhenmei Yang et al. · 2020 · Journal of Controlled Release
  14. Myeloid-Derived Suppressor Cells: A New and Pivotal Player in Colorectal Cancer Progression
    Kai Yin, Xueli Xia, Ke Rui, Tingting Wang, Shengjun Wang · 2020 · Frontiers in Oncology
  15. Cargo-free immunomodulatory nanoparticles combined with anti-PD-1 antibody for treating metastatic breast cancer
    Yining Zhang, Kevin R. Hughes, Ravi M. Raghani, Jeffrey A. Ma, Sophia M. Orbach, Jacqueline Sara Jeruss, Lonnie D. Shea · 2021 · Biomaterials
  16. Homeobox B5 promotes metastasis and poor prognosis in Hepatocellular Carcinoma, via FGFR4 and CXCL1 upregulation
    Qin He, Wenjie Huang, Danfei Liu, Tongyue Zhang, Yijun Wang, Xiaoyu Ji, Meng Xie, Mengyu Sun, Dean Tian, Mei Liu et al. · 2021 · Theranostics
  17. Tumor Microenvironment of Esophageal Cancer
    Lars Mortimer Schiffmann, Patrick Sven Plum, Hans Friedrich Fuchs, Benjamin Babic, Christiane J. Bruns, Thomas Schmidt · 2021 · Cancers
  18. Fatty Acid Metabolism in Myeloid-Derived Suppressor Cells and Tumor-Associated Macrophages: Key Factor in Cancer Immune Evasion
    Sophiya Siddiqui, Rainer Glauben · 2022 · Cancers
  19. TGF-β Enhances Immunosuppression of Myeloid-Derived Suppressor Cells to Induce Transplant Immune Tolerance Through Affecting Arg-1 Expression
    Peng Cao, Zejia Sun, Feilong Zhang, Jiandong Zhang, Zheng Xiang, Baozhong Yu, Yong Xiang Zhao, Wei Wang, Wei Wang · 2022 · Frontiers in Immunology
  20. A review concerning the breast cancer-related tumour microenvironment
    Oscar Hernán Rodríguez-Bejarano, Carlos Parra-López, Manuel Alfonso Patarroyo · 2024 · Critical Reviews in Oncology/Hematology
  21. Cellular mechanisms of combining innate immunity activation with PD-1/PD-L1 blockade in treatment of colorectal cancer
    Qi Xie, Xiaolin Liu, Rengyun Liu, Jingxuan Pan, Jing Liang · 2024 · Molecular Cancer
  22. Mechanisms overseeing myeloid-derived suppressor cell production in neoplastic disease
    Colleen S. Netherby, Scott I. Abrams · 2017 · Cancer Immunology Immunotherapy
  23. STAT1 gene deficient mice develop accelerated breast cancer growth and metastasis which is reduced by IL-17 blockade
    Sanjay Varikuti, Steve Oghumu, Mohamad Elbaz, Greta Volpedo, Dinesh Kumar Ahirwar, Pablo C. Alarcon, Rachel H. Sperling, Ellen Moretti, Marissa S. Pioso, Jennifer Kimble et al. · 2017 · OncoImmunology
  24. Rhesus Macaque Myeloid-Derived Suppressor Cells Demonstrate T Cell Inhibitory Functions and Are Transiently Increased after Vaccination
    Ang Lin, Frank Liang, Elizabeth A. Thompson, Maria Vono, Sebastian Ols, Gustaf Lindgren, Kimberly J. Hassett, Hugh Salter, Giuseppe Ciaramella, Karin Loré · 2017 · The Journal of Immunology
  25. miR-130a and miR-145 reprogram Gr-1+CD11b+ myeloid cells and inhibit tumor metastasis through improved host immunity
    Hiroki Ishii, Suman Kumar Vodnala, Bhagelu R. Achyut, Jae Young So, Mary Christine Hollander, Tim F. Greten, Ashish Lal, Yang Li · 2018 · Nature Communications
  26. Myeloid-Derived Suppressor Cells as a Regulator of Immunity in Organ Transplantation
    Tsukasa Nakamura, Hidetaka Ushigome · 2018 · International Journal of Molecular Sciences
  27. Candida/Staphylococcal Polymicrobial Intra-Abdominal Infection: Pathogenesis and Perspectives for a Novel Form of Trained Innate Immunity
    Shannon K. Esher, Paul L. Fidel, Mairi C. Noverr · 2019 · Journal of Fungi
  28. Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor’s arsenal
    Clara S. Mundry, Kirsten C. Eberle, Pankaj K. Singh, Michael Anthony Hollingsworth, Kamiya Mehla · 2020 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  29. Integrating Circulating Biomarkers in the Immune Checkpoint Inhibitor Treatment in Lung Cancer
    Boris Duchemann, Jordi Remón, Marie Naigeon, Laura Mezquita, Roberto Ferrara, Lydie Cassard, Jean-Mehdi Jouniaux, Lisa Boselli, Jonathan Grivel, Édouard Auclin et al. · 2020 · Cancers
  30. Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies
    Sunčica Kapor, Juan Francisco Santibanez · 2021 · Journal of Clinical Medicine
  31. Inflammation and Myeloid Cells in Cancer Progression and Metastasis
    Jenying Deng, Jason B. Fleming · 2022 · Frontiers in Cell and Developmental Biology
  32. Long Noncoding RNA MIR4435-2HG Suppresses Colorectal Cancer Initiation and Progression By Reprogramming Neutrophils
    Hongfei Yu, Chaoyi Chen, Fengyan Han, Jinlong Tang, Mengli Deng, Yumiao Niu, Maode Lai, Honghe Zhang · 2022 · Cancer Immunology Research
  33. Myeloid-driven mechanisms as barriers to antitumor CD8+ T cell activity
    Sean H. Colligan, Stephanie L. Tzetzo, Scott I. Abrams · 2019 · Molecular Immunology
  34. Mechanisms Underlying the Role of Myeloid-Derived Suppressor Cells in Clinical Diseases: Good or Bad
    Yongtong Ge, Dalei Cheng, Qingzhi Jia, Huabao Xiong, Junfeng Zhang · 2021 · Immune Network
  35. Altered intraperitoneal immune microenvironment in patients with peritoneal metastases from gastric cancer
    Kazuya Takahashi, Kentaro Kurashina, Hironori Yamaguchi, Rihito Kanamaru, Hideyuki Ohzawa, Hideyo Miyato, Shin Saito, Yoshinori Hosoya, Alan Kawarai Lefor, Naohiro Sata et al. · 2022 · Frontiers in Immunology
  36. Understanding the squamous cell carcinoma immune microenvironment
    Vahide Saeidi, Nicole Adell Doudican, John A. Carucci · 2023 · Frontiers in Immunology
  37. The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer—Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy
    Katarzyna Starska · 2023 · Cancers
  38. The recent progress of myeloid‐derived suppressor cell and its targeted therapies in cancers
    Ruiyang Ren, Chenyi Xiong, Runyu Ma, Yixuan Wang, Tianyang Yue, Jiayun Yu, Bin Shao · 2023 · MedComm
  39. Neutrophil infiltration associated genes on the prognosis and tumor immune microenvironment of lung adenocarcinoma
    Renwang Liu, Guangsheng Zhu, Yonglin Sun, Mingbiao Li, Zixuan Hu, Peijun Cao, Xuanguang Li, Zuoqing Song, Jun Chen · 2023 · Frontiers in Immunology
  40. Overcoming immunotherapy resistance in hepatocellular carcinoma by targeting myeloid IL-8/CXCR2 signaling
    Tsz Tung Kwong, Zhewen Xiong, Yiling Zhang, Haoran Wu, Jian Cao, Patrick Pak-Chun Wong, Xiaoyu Liu, Jing Wang, Chi Hang Wong, Gary Man-Kit Tse et al. · 2025 · Molecular Therapy
  41. IL4-induced gene 1 promotes tumor growth by shaping the immune microenvironment in melanoma
    Lloyd Bod, Renée Lengagne, Ludovic Jean Wrobel, Jan Philipp Ramspott, Masashi Kato, Marie‐Françoise Avril, Flavia Castellano, Valérie Molinier‐Frenkel, Armelle Prévost‐Blondel · 2017 · OncoImmunology
  42. Role of myeloid-derived suppressor cells in allogeneic hematopoietic cell transplantation
    Brent H. Koehn, Bruce R. Blazar · 2017 · Journal of Leukocyte Biology
  43. Myeloid-derived suppressor cells in gliomas
    Anna Gieryng, Bozena Kaminska · 2016 · Współczesna Onkologia
  44. Energy metabolism drives myeloid-derived suppressor cell differentiation and functions in pathology
    Antonio Sica, Laura Strauss · 2017 · Journal of Leukocyte Biology
  45. Myeloid-derived suppressor cell and macrophage exert distinct angiogenic and immunosuppressive effects in breast cancer
    Zhaoxu Fang, Chengwen Wen, Xiaolan Chen, Rongping Yin, Chenglin Zhang, Xiaohua Wang, Yuhui Huang · 2017 · Oncotarget
  46. Metabolic regulation of suppressive myeloid cells in cancer
    Antonio Sica, Laura Strauss, Francesca Maria Consonni, Cristina Travelli, Armando A. Genazzani, Chiara Porta · 2017 · Cytokine & Growth Factor Reviews
  47. Human neutrophils can mimic myeloid-derived suppressor cells (PMN-MDSC) and suppress microbead or lectin-induced T cell proliferation through artefactual mechanisms
    Dmitri G. Negorev, Ulf Henning Beier, Tianyi Zhang, Jon G. Quatromoni, Pratik Sanjivkumar Bhojnagarwala, Steven Μ. Albelda, Sunil Kumar Singhal, Evgeniy B. Eruslanov, Falk W. Lohoff, Matthew H. Levine et al. · 2018 · Scientific Reports
  48. Myeloid-derived suppressor cells in non-neoplastic inflamed organs
    Sho Sendo, Jun Saegusa, Akio Morinobu · 2018 · Inflammation and Regeneration
  49. SMAC Mimetic Debio 1143 and Ablative Radiation Therapy Synergize to Enhance Antitumor Immunity against Lung Cancer
    Zhen Tao, Neal S. McCall, Norbert Wiedemann, Grégoire Vuagniaux, Zhiyong Yuan, Bo Lü · 2018 · Clinical Cancer Research
  50. The Potential for Cancer Immunotherapy in Targeting Surgery-Induced Natural Killer Cell Dysfunction
    Marisa Market, Katherine E. Baxter, Leonard Angka, Michael A. Kennedy, Rebecca C. Auer · 2018 · Cancers
  51. CCL7 Is a Negative Regulator of Cutaneous Inflammation Following Leishmania major Infection
    Jill W. Ford, Angela L. Hughson, Kihong Lim, Susana V. Bardina, Wuyuan Lu, Israel F. Charo, Jean K. Lim, Deborah J. Fowell · 2019 · Frontiers in Immunology
  52. The presence and suppressive activity of myeloid-derived suppressor cells are potentiated after interferon-β treatment in a murine model of multiple sclerosis
    Carolina Melero‐Jerez, Margarita Suardíaz, Rafael Lebrón‐Galán, Carmen Marín-Bañasco, Begoña Oliver‐Martos, Isabel Machín-Díaz, Óscar Fernández, Fernando de Castro, Diego Clemente · 2019 · Neurobiology of Disease
  53. PAR2 deficiency enhances myeloid cell-mediated immunosuppression and promotes colitis-associated tumorigenesis
    Ziliang Ke, Chaohui Wang, Ting Wu, Weihong Wang, Yong Yang, Yun Dai · 2019 · Cancer Letters
  54. Immunometabolism in the pathogenesis of systemic lupus erythematosus
    Chenxing Zhang, Huiyu Wang, Lei Yin, Youying Mao, Wei Zhou · 2020 · Journal of Translational Autoimmunity
  55. The tumour immune landscape and its implications in cutaneous melanoma
    Grace Heloise Attrill, Peter M. Ferguson, Umaimainthan Palendira, Georgina Venetia Long, James S. Wilmott, Richard A. Scolyer · 2020 · Pigment Cell & Melanoma Research
  56. Dissecting heterogeneous cell populations across drug and disease conditions with PopAlign
    Sisi Chen, Paul Rivaud, Jong‐Hwan Park, Tiffany Tsou, Emeric J. Charles, John R. Haliburton, Flavia Pichiorri, Matt W. Thomson · 2020 · Proceedings of the National Academy of Sciences
  57. Moonlighting Proteins Are Important Players in Cancer Immunology
    Annalisa Adamo, Cristina Frusteri, Maria Teresa Pallotta, Tracey Pirali, Silvia Sartoris, Stefano Ugel · 2021 · Frontiers in Immunology
  58. The Role of Myeloid-Derived Suppressor Cells (MDSCs) in Graft-versus-Host Disease (GVHD)
    Christos Demosthenous, Ioanna Sakellari, Vassiliki Douka, Penelope Georgia Papayanni, Αchilles Anagnostopoulos, Eleni Gavriilaki · 2021 · Journal of Clinical Medicine
  59. Abscopal Effect of Radiotherapy Enhanced with Immune Checkpoint Inhibitors of Triple Negative Breast Cancer in 4T1 Mammary Carcinoma Model
    Haa‐Na Song, Hana Jin, Junghoon Kim, In‐Bong Ha, Ki-Mun Kang, Hoon‐Sik Choi, Hojin Jeong, Minyoung Kim, Hye Jung Kim, Bae Kwon Jeong · 2021 · International Journal of Molecular Sciences
  60. Tumor-Infiltrating Myeloid Cells Co-Express TREM1 and TREM2 and Elevated TREM-1 Associates With Disease Progression in Renal Cell Carcinoma
    Jill W. Ford, Marieli Gonzalez-Cotto, Alexander W. Macfarlane, Suraj Peri, O. M. Zack Howard, Jeffrey J. Subleski, Karen J Ruth, Mohammed Haseebuddin, Tahseen Al‐Saleem, Youfeng Yang et al. · 2022 · Frontiers in Oncology
  61. Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin
    Shunjie Yu, Xiaotong Ren, Lijuan Li · 2022 · Experimental Hematology and Oncology
  62. The Immunotherapy and Immunosuppressive Signaling in Therapy-Resistant Prostate Cancer
    Pengfei Xu, Logan J. Wasielewski, Joy C. Yang, Demin Cai, Christopher P. Evans, William J. Murphy, Chengfei Liu · 2022 · Biomedicines
  63. Myeloid‑derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in colorectal cancer (Review)
    Wenjuan Zeng, Haohan Liu, Yuanhao Mao, Shihao Jiang, Yi Hao, Zitong Zhang, Menghui Wang, Zhen Zong · 2024 · International Journal of Oncology
  64. Neutrophil, quo vadis?
    Jadwiga Jabłońska, Zvi Granot · 2017 · Journal of Leukocyte Biology
  65. Lymphocyte Antigen 6 Complex, Locus C+ Monocytes and Kupffer Cells Orchestrate Liver Immune Responses Against Hepatitis B Virus in Mice
    Li‐Ling Wu, Wei‐Hao Peng, Hui‐Lin Wu, Shi‐Chuen Miaw, Shiou‐Hwei Yeh, Hung‐Chih Yang, Pei-Hsuan Liao, Jing‐Shan Lin, Yan‐Rong Chen, Yen‐Tien Hong et al. · 2019 · Hepatology
  66. CD66b+ monocytes represent a proinflammatory myeloid subpopulation in cancer
    Utku Horzum, Diğdem Yöyen-Ermiş, Ekim Z. Taşkıran, Kerim Bora Yılmaz, Erhan Hamaloğlu, Derya Karakoç, Güneş Esendağlı · 2020 · Cancer Immunology Immunotherapy
  67. Detection of response to tumor microenvironment–targeted cellular immunotherapy using nano-radiomics
    Laxman Devkota, Z. Starosolski, Charlotte H. Rivas, I. Stupin, A. Annapragada, K. Ghaghada, R. Parihar · 2020 · Science Advances
  68. Implications of metabolism-driven myeloid dysfunctions in cancer therapy
    Laura Strauss, Valentina Guarneri, Alessandra Gennari, Antonio Sica · 2020 · Cellular and Molecular Immunology
  69. Mechanism of tumour microenvironment in the progression and development of oral cancer
    Mohd Mughees, Anindita Sengupta, Sapna Khowal, Saima Wajid · 2021 · Molecular Biology Reports
  70. Effect of Immune Checkpoint Blockade on Myeloid-Derived Suppressor Cell Populations in Patients With Melanoma
    Steven H. Sun, Brooke N. Benner, Himanshu Savardekar, Gabriella Lapurga, Logan Good, David Abood, Erin Nagle, Megan Christina Duggan, Andrew R. Stiff, Mallory J. DiVincenzo et al. · 2021 · Frontiers in Immunology
  71. Role of inflammatory microenvironment: potential implications for improved breast cancer nano-targeted therapy
    Meng Lan, Wenping Lü, Tengteng Zou, Lihong Li, Fengjie Liu, Tiange Cai, Yu Cai · 2021 · Cellular and Molecular Life Sciences
  72. Myeloid-Derived Suppressor Cell Differentiation in Cancer: Transcriptional Regulators and Enhanceosome-Mediated Mechanisms
    Norman Fultang, Xinyuan Li, Ting Li, Youhai H. Chen · 2021 · Frontiers in Immunology
  73. Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19
    Marianna Rowlands, Florencia Segal, Dominik Hartl · 2021 · Frontiers in Immunology
  74. Biological characteristics of pancreatic ductal adenocarcinoma: Initiation to malignancy, intracellular to extracellular
    Ou Li, Li Li, Yunru Sheng, Kun Ke, Jianzhang Wu, Yiping Mou, Mingyang Liu, Weiwei Jin · 2023 · Cancer Letters
  75. Arginase-1 Expression in Myeloid Cells Regulates Staphylococcus aureus Planktonic but Not Biofilm Infection
    Kelsey J. Yamada, Cortney E. Heim, Amy L. Aldrich, Casey M. Gries, Anna G. Staudacher, Tammy Kielian · 2018 · Infection and Immunity
  76. The potential importance of myeloid-derived suppressor cells (MDSCs) in the pathogenesis of Alzheimer’s disease
    Antero Salminen, Kai Kaarniranta, Anu Kauppinen · 2018 · Cellular and Molecular Life Sciences
  77. Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment
    Marie‐Nicole Theodoraki, Saigopalakrishna S. Yerneni, Saumendra N. Sarkar, Brian Christopher Orr, Ravikumar Muthuswamy, Jamie Voyten, Francesmary Modugno, Weijian Jiang, Melissa J. Grimm, Per H. Basse et al. · 2018 · Cancer Research
  78. Prime and Boost Vaccination Elicit a Distinct Innate Myeloid Cell Immune Response
    Jean‐Louis Palgen, Nicolas Tchitchek, Jamila Elhmouzi‐Younes, Simon Delandre, Inana Namet, Pierre Rosenbaum, Nathalie Dereuddre‐Bosquet, Frédéric Martinon, Antonio Cosma, Yves Lévy et al. · 2018 · Scientific Reports
  79. Platelets contribute to the initiation of colitis‐associated cancer by promoting immunosuppression
    Laurence Servais, Odile Wéra, John Dibato Epoh, Céline Delierneux, Nassim Bouznad, Souad Rahmouni, Gabriel Mazzucchelli, Dominique Baiwir, Philippe Delvenne, Patrizio Lancellotti et al. · 2018 · Journal of Thrombosis and Haemostasis
  80. Myeloid‐derived suppressor cells and tumor: Current knowledge and future perspectives
    Elahe Safari, Sajjad Ghorghanlu, Homayoun Ahmadi‐khiavi, Sahar Mehranfar, Ramazan Rezaei, Morteza Motallebnezhad · 2018 · Journal of Cellular Physiology
  81. Cell Therapy With Mesenchymal Stem Cells Induces an Innate Immune Memory Response That Attenuates Experimental Colitis in the Long Term
    Mercedes López‐Santalla, Rosario Hervás-Salcedo, María Fernández-García, Juan Antonio Bueren, Marina Inmaculada Garin · 2020 · Journal of Crohn s and Colitis
  82. Immunological Endotyping of Chronic Critical Illness After Severe Sepsis
    Brittany P. Fenner, Dijoia B. Darden, Lauren S. Kelly, Jaimar C. Rincon, Scott C. Brakenridge, Shawn D. Larson, Frederick Alan Moore, Philip Alexander Efron, Lyle L. Moldawer · 2021 · Frontiers in Medicine
  83. The role of myeloid‐derived suppressor cells in gastrointestinal cancer
    Cheng Cui, Penglin Lan, Li Fu · 2021 · 癌症:英文版
  84. Albumin Nanoparticle Endocytosing Subset of Neutrophils for Precision Therapeutic Targeting of Inflammatory Tissue Injury
    Kurt Bachmaier, Andrew Stuart, Abhalaxmi Singh, Amitabha Mukhopadhyay, Sreeparna Chakraborty, Zhigang Hong, Li Wang, Yoshikazu Tsukasaki, Mark Maienschein‐Cline, Balaji B. Ganesh et al. · 2022 · ACS Nano
  85. Posttransplantation cyclophosphamide expands functional myeloid-derived suppressor cells and indirectly influences Tregs
    Rochelle Fletcher, Natalia S. Nunes, Michael T. Patterson, Natasha Vinod, Shanzay M. Khan, Suresh Kumar Mendu, Xianghong Li, Alessandra de Paula Pohl, Lucas P. Wachsmuth, Hyoyoung Choo‐Wosoba et al. · 2023 · Blood Advances
  86. Delayed persistence of elevated monocytic MDSC associates with deleterious outcomes in septic shock: a retrospective cohort study
    Louis Waeckel, Fabienne Venet, Morgane Gossez, Céline Monard, Thomas R. Rimmele, Guillaume Monneret · 2020 · Critical Care
  87. Role of myeloid-derived suppressor cells in viral respiratory infections; Hints for discovering therapeutic targets for COVID-19
    Khadijeh Koushki, Maryam Salemi, Seyed Mohammad Miri, Yaser Arjeini, Mohsen Keshavarz, Amir Ghaemi · 2021 · Biomedicine & Pharmacotherapy
  88. TGF-β orchestrates the phenotype and function of monocytic myeloid-derived suppressor cells in colorectal cancer
    Luciana Gneo, Nagy Rizkalla, Rahul K. Hejmadi, Francis Mussai, Carmela De Santo, Gary Middleton · 2021 · Cancer Immunology Immunotherapy
  89. Identification of TREM2-positive tumor-associated macrophages in esophageal squamous cell carcinoma: implication for poor prognosis and immunotherapy modulation
    Hongmu Li, Miao Yu, Leqi Zhong, Songjie Feng, Yue Xu, Lu Tang, Chun Jing Wu, Xianzhou Zhang, Ling Gu, Hengyi Diao et al. · 2023 · Frontiers in Immunology
  90. The complex interplay between neutrophils and cancer
    Andrea Rakic, Paul Beaudry, Douglas J. Mahoney · 2018 · Cell and Tissue Research
  91. Hydrogen Sulfide Reduces Myeloid-Derived Suppressor Cell-Mediated Inflammatory Response in a Model of Helicobacter hepaticus-Induced Colitis
    Paola De Cicco, Theodore J. Sanders, Giuseppe Cirino, Kevin Joseph Maloy, Angela Ianaro · 2018 · Frontiers in Immunology
  92. Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy
    Emile J. Clappaert, Aleksandar Murgaski, Helena Van Damme, Máté Kiss, Damya Laoui · 2018 · Frontiers in Immunology
  93. Crosstalk between myeloid-derived suppressor cells and the immune system in prostate cancer
    Mohammad‐Javad Sanaei, Loghman Salimzadeh, Nader Bagheri · 2019 · Journal of Leukocyte Biology
  94. Ping-Pong—Tumor and Host in Pancreatic Cancer Progression
    Wei Mu, Zhe Wang, Margot Zöller · 2019 · Frontiers in Oncology
  95. Dual photothermal MDSCs-targeted immunotherapy inhibits lung immunosuppressive metastasis by enhancing T-cell recruitment
    Kalliopi Domvri, Savvas Petanidis, Doxakis Anestakis, Κonstantinos Porpodis, Chong Bai, Paul Zarogoulidis, Lutz Freitag, Wolfgang Hohenforst‐Schmidt, Theodora Katopodi · 2020 · Nanoscale
  96. Circulating and tumor-infiltrating arginase 1-expressing cells in gastric adenocarcinoma patients were mainly immature and monocytic Myeloid-derived suppressor cells
    Weihong Ren, XuRan Zhang, WenBo Li, Qian Feng, Huijie Feng, Yan Tong, Hao Rong, Wei Wang, Dai Zhang, Zhenqiang Zhang et al. · 2020 · Scientific Reports
  97. Immune-Related Gene Expression and Cytokine Secretion Is Reduced Among African American Colon Cancer Patients
    Jenny E. Paredes, Jovanny Zabaleta, Jone Garai, Ping Ji, Sayed Imtiaz, Marzia Spagnardi, Joussette I. Alvarado, Li Li, Mubarak Akadri, Kaylene Barrera et al. · 2020 · Frontiers in Oncology
  98. Myeloid-Derived Suppressor Cells: Implications in the Resistance of Malignant Tumors to T Cell-Based Immunotherapy
    Houhui Shi, Kai Li, Yanghong Ni, Xiao Liang, Xia Zhao · 2021 · Frontiers in Cell and Developmental Biology
  99. Neutrophils as an emerging therapeutic target and tool for cancer therapy
    Md Abdus Subhan, Vladimir P. Torchilin · 2021 · Life Sciences
  100. Regulating Histone Deacetylase Signaling Pathways of Myeloid-Derived Suppressor Cells Enhanced T Cell-Based Immunotherapy
    Adeleye Oluwatosin Adeshakin, Funmilayo Oladunni Adeshakin, Dehong Yan, Xiaochun Wan · 2022 · Frontiers in Immunology